Point of Care Molecular Diagnostics Market Growing at a CAGR of 14.7%

The global point of care molecular diagnostics market was valued at USD 632.5 Million in 2017 and is projected to reach USD 1,440.2 Million in 2023, at a CAGR of 14.7%

The scope of the study includes POC molecular diagnostics analyzers and assays that enable healthcare professionals in the detection of diseases through molecular technologies in point-of-care settings. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143524127

The key players in the global Point of care molecular diagnostics market are, Roche Diagnostics (Switzerland), Biomerieux (France), Danaher (US), Abbott Laboratories (US), Quidel (US) and Meridian Bioscience (US).

Target Audience:

• POC Molecular Diagnostics Manufacturers
• Physicians
• Research Institutes
• Diagnostics Suppliers
• Market Research and Consulting Firms
• Regulatory Bodies
• Venture Capitalists

The POC molecular diagnostics market is segmented into RT-PCR, INAAT, and others technologies. In 2018, the RT-PCR segment is expected to account for the largest share of the global POC molecular diagnostics market. 

The large share of this segment can be attributed to the growing use of RT-PCR in proteomics and genomics and access to portable, easy-to-use devices. In the last three years from 2015, more than 42 RT-PCR based products have been launched for various diseases.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html